Skip to main content
Transforming healthcare research | Accelerating Drug Discovery | Transforming Health with Integrity and Innovation
Back to Leadership Team Experience

Observational programs & registries

Large real-world programs that track blood pressure control, tolerability and long-term outcomes.

Led by: Prof. Dike Ojiji

  • Completed

    Observational Program to assess Blood Pressure Control and Tolerability of Perindopril-Amlodipine Fixed-Dose Combination, with or without Diuretics, in Nigeria (13-City Hypertension Study)

  • Completed

    Clinical Outcomes in 3343 Children and Adults with Rheumatic Heart Disease from 14 Low and Middle Income Countries: 2-Year Follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY study)